Novartis AG
SWXNOVN enters the week down 8% over the past month, closing Tuesday at CHF 113.54. The most striking tension here is the gap between insider behaviour — persistent and sizeable selling — and an analyst community that sees nearly 37% upside to a mean target of CHF 154.95. Insider activity has been a consistent one-way trade. In the 90 days to end-March, undisclosed executives and a…
Snapshot as of 6 May 2026
A new long-form analysis for NOVN this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumNOVN enters the week down 8% over the past month, closing Tuesday at CHF 113.54. The most striking tension here is the gap between insider behaviour — persistent and sizeable selling — and an analyst community that…
NOVN arrives at its Q1 2026 results today with one of the most striking setup features being the near-complete retreat of short sellers over the past six weeks. Short interest has collapsed. The SI % of free float has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NOVN — free to start on ORTEX.
Sign up for free →Open NOVN on ORTEX